Citeline：2025医药研发年度回顾白皮书（英文版）（66页）.pdf

1、WHITE PAPERFind out whats in and out of fashionin drug development with our analysisof this years key pipeline trends.Powered by Pharmaprojec tsWhy did Pfizer regain its crown?How come everybodys looking at China?Welcome 0303Introduction:Total Pipeline Size 05 05 Pharma has more material than ever b

2、efore Following the Pattern:The 2025 Pipeline by Phase of Development 07 07 Can the industry cut its clinical coat according to its cloth?Top Companies 10 10 Vintage names look solid,while boutique firms flourish Therapies and Diseases 18 18 Cancer still en vogue,but have we reached peak oncology?Re

3、gional Variations 2828The leading players in key markets,and the varying styles of drug R&DMechanisms and Targets 4747Immuno-oncology continues to be the trend everyone is followingTypes of Pipeline Drugs 5252Biotech struts its stuff on the pharma catwalk Whats the Forecast for Pharma?61 61Is th

4、e pharma industry still wearing the trousers,or might it be caught with its pants down?About the Author 6666ContentsContentsWelcome to Pharmaprojects 2025 review of trends in pharmaceutical R&D Welcome to Pharmaprojects 2025 review of trends in pharmaceutical R&D.For over 30 years now,Ive be

5、en taking an annual look at the evolution of pharma R&D,and in this article,Ill investigate how fashions are changing in the industry at the start of 2025.Well assess industry trends by examining the pipeline by company,therapeutic area,disease,target,and drug type,using data primarily from Phar

6、maprojects,part of the Citeline suite of products,which has been tracking global drug development since 1980.This report will be followed up by our annual supplement reviewing the New Active Substance(NAS)launches for the year just passed.But here,well roll up our sleeves to examine how pharma R&